Portal to the Penn Neuroscience Community

Home

MINS Members

MINS News

Weekly Events

MINS Colloquium Schedule

History

Community Outreach Programs

Neuroscience Graduate Group
Other Educational Activities

Society for Neuroscience

Classified Ads

 MINS Members

Elliot V. Hersh, Ph.D.

Research Interests

controlled clinical trials of analgesic and local anesthetic agents

Research Summary

Dr. Hersh is currently a Professor of Oral Surgery and Pharmacology and Director of the Division of Pharmacology and Therapeutics, at the University of Pennsylvania School of Dental Medicine. He also serves as one the Chairs of the Committee on Studies Involving Human Beings at the University. He received his DMD (1981), MS (1983) and PhD (1988) degrees from the University of Medicine and Dentistry in Newark, New Jersey.

Since coming to the University of Pennsylvania he has won numerous teaching honors including the School of Dental Medicine's Basic Science Teaching Award 11 of the last 14 years and the University of Pennsylvania's Lindback Award for Distinguished Teaching, the highest teaching honor bestowed by the University. He has been an invited lecturer to numerous dental and medical organizations throughout the United States and Canada. Dr. Hersh has more than 90 publications, scientific abstracts and book chapters to his credit and has conducted numerous clinical trials in the areas of local anesthesia and postoperative pain control.

He has been one of the principal investigators in the clinical development of such products as OTC ketoprofen (Orudis® KT), ibuprofen liquigel (Advil® Liquigels), extended-release etodolac (Lodine® -XL), and the lidocaine transmucosal patch (Dentipatch®) to name a few. He is on the editorial board of the journals Clinical Therapeutics, Current Medical Research and Opinion and the Journal of Clinical Dentistry, and serves as an outside reviewer for other scholarly journals including the Journal of Clinical Pharmacology, and the Journal of the American Dental Association.

He is a former President of, and continues to serve as Councilor of the Pharmacology, Toxicology and Therapeutics Section of the International Association of Dental Research.